FARXIGA
- Product NDC
- 55154-6932
- 11-digit product format
- 551546932
- Labeler code
- 55154
- Product ID
- 55154-6932_26402823-3884-4994-93d1-19b57eb71cb4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPAGLIFLOZIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Cardinal Health 107, LLC
- Application
- NDA202293
- Marketing category
- NDA
- Marketing start
- 2008-01-14
- Marketing end
- 0000-00-00
- Substance
- DAPAGLIFLOZIN PROPANEDIOL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55154-6932-8 | FARXIGA | 1440 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1440 | | 20 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55154-6932 | FARXIGA (DAPAGLIFLOZIN) TABLET, FILM COATED [CARDINAL HEALTH 107, LLC] | 20 | Legacy NDC, 1 package rows | 20240901_40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55154-6932-8 | 55154693208 | 1440 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6932-8) | 2015-02-02 | 0000-00-00 | No | No | Current |